Mersana Therapeutics Inc at Jefferies Healthcare Conference Transcript
Good morning, and welcome to the Jefferies 2023 Healthcare Investment Banking Conference. It's my great pleasure to introduce Brian DeSchuytner from Mersana Therapeutics.
All right. Thanks so much, and thank you to Jefferies for hosting us today. Please advance the slides.
Just as a reminder, I'll be making forward-looking statements today in this presentation. Important disclosures about those statements and the risk can be found in our SEC filings available at sec.gov.
So Mersana was founded about a decade ago as an ADC company, with the recognition that ADCs were a validated modality, but one that had certain limitations from the first-generation platforms. So we set out to develop a suite of technologies that would address some of those limitations. And today, we find ourselves with three proprietary platforms: two delivering a cytotoxic and one delivering an immune stimulator.
We find ourselves with a lead asset, UpRi, on the verge of a pivotal
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
